Dr. Slosky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 Highland Ave
Madison, WI 53792Phone+1 608-263-1530Fax+1 608-265-8887
Summary
- Dr. David Slosky is a Cardiovascular Oncologist in Nashville, TN and is a retired faculty member at Vanderbilt Medical Center and works part time @ the University of Wisconsin Medical Center in Madison, Wisconsin. He is a clinical Assistant Professor of Medicine. He received his medical degree from University of Colorado School of Medicine and has been in practice for more than 30years. He specializes in cardiovascular oncology and is experienced in cardiac catheterization, healthcare quality, and amyloidosis and clonal heamatopoiesis of indeterminate potential (CHIP)
Education & Training
- Duke University HospitalFellowship, Cardiovascular Disease, 1978 - 1981
- Duke University HospitalResidency, Internal Medicine, 1976 - 1978
- University of Colorado School of Medicine Anschutz Medical CampusClass of 1976, MD
Certifications & Licensure
- TN State Medical License 2005 - 2026
- DE State Medical License 2023 - 2025
- WI State Medical License 1981 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow Society of Cardiovascular Angiography & Interventions SCAI, 2007
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 1439 citationsFulminant Myocarditis with Combination Immune Checkpoint BlockadeDouglas B. Johnson, Justin M. Balko, Margaret L. Compton, Spyridon Chalkias, Joshua M. Gorham
The New England Journal of Medicine. 2016-11-02 - 28 citationsOutcomes in patients with cardiac amyloidosis and implantable cardioverter-defibrillator.Eun-jeong Kim, Benjamin Holmes, Shi Huang, Ricardo M. Lugo, Asad A. Aboud
Europace. 2020-08-01 - 20 citationsA Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance.Maheen Z. Abidi, David M. Aboulafia, Melissa K. Accordino, Jared D. Acoba, Manmeet Ahluwalia
Cancer Cell. 2020-12-14
Press Mentions
- Keeping Cancer Drugs from Causing Heart DamageMay 18th, 2016
- Cancer Treatments Can Be Tough on the HeartApril 1st, 2016
- Drug Might Help Breast Cancer Patients Avoid Heart DamageNovember 11th, 2015
- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- Spanish
Industry Relationships
- Chief Medical Officer, Rare Disease Data Trust2023 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: